Effipride MV 2mg/500mg/0.2mg Tablet SR
Marketer
Efficus Life Sciences And Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Effipride MV 2mg/500mg/0.2mg Tablet SR
DiabetaComb SR (2mg/500mg/0.2mg) tablets are a combination antidiabetic medication for adult-onset type 2 diabetes. This formulation helps regulate blood glucose. Administer DiabetaComb SR with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. DiabetaComb SR is part of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify its symptoms—sweating, dizziness, headache, tremors—and how to manage them. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. DiabetaComb SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Effipride MV 2mg/500mg/0.2mg Tablet SR
No information provided. Please provide the text you wish me to rewrite.
Uses of Effipride MV 2mg/500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Effipride MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Effipride MV 2mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet on an empty stomach.
Common Side effects of Effipride MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Effipride MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Effipride MV 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Effipride MV 2mg/500mg/0.2mg Tablet SR works:
Each Effipride MV SR tablet (2mg/500mg/0.2mg) contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Effipride MV 2mg/500mg/0.2mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Effipride MV 2mg/500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice from your doctor.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Effipride MV 2mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Effipride MV 2mg/500mg/0.2mg sustained-release tablets carries a high risk for individuals with kidney impairment and should be strictly avoided. Patients with severe kidney disease should not take this medication. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Effipride MV 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a reduced dose; the medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Effipride MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Effipride MV 2mg/500mg/0.2mg Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Effipride MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently